Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity

Maria Abad, Hisayuki Hashimoto, Huanyu Zhou, Maria Gabriela Morales, Beibei Chen, Rhonda Bassel-Duby, Eric N. Olson

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Conversion of fibroblasts into functional cardiomyocytes represents a potential means of restoring cardiac function after myocardial infarction, but so far this process remains inefficient and little is known about its molecular mechanisms. Here we show that DAPT, a classical Notch inhibitor, enhances the conversion of mouse fibroblasts into induced cardiac-like myocytes by the transcription factors GATA4, HAND2, MEF2C, and TBX5. DAPT cooperates with AKT kinase to further augment this process, resulting in up to 70% conversion efficiency. Moreover, DAPT promotes the acquisition of specific cardiomyocyte features, substantially increasing calcium flux, sarcomere structure, and the number of spontaneously beating cells. Transcriptome analysis shows that DAPT induces genetic programs related to muscle development, differentiation, and excitation-contraction coupling. Mechanistically, DAPT increases binding of the transcription factor MEF2C to the promoter regions of cardiac structural genes. These findings provide mechanistic insights into the reprogramming process and may have important implications for cardiac regeneration therapies.

Original languageEnglish (US)
Pages (from-to)548-560
Number of pages13
JournalStem Cell Reports
Volume8
Issue number3
DOIs
StatePublished - Mar 14 2017

Fingerprint

Fibroblasts
Cardiac Myocytes
GATA4 Transcription Factor
MEF2 Transcription Factors
Genetic Promoter Regions
Conversion efficiency
Muscle
Excitation Contraction Coupling
Sarcomeres
Phosphotransferases
Muscle Development
Genes
Gene Expression Profiling
Fluxes
Calcium
Regeneration
Myocardial Infarction
Therapeutics

Keywords

  • cardiomyocytes
  • cell-fate conversion
  • DAPT
  • direct cellular reprogramming
  • heart regeneration
  • Notch signaling
  • regenerative medicine
  • transdifferentiation

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. / Abad, Maria; Hashimoto, Hisayuki; Zhou, Huanyu; Morales, Maria Gabriela; Chen, Beibei; Bassel-Duby, Rhonda; Olson, Eric N.

In: Stem Cell Reports, Vol. 8, No. 3, 14.03.2017, p. 548-560.

Research output: Contribution to journalArticle

Abad, Maria ; Hashimoto, Hisayuki ; Zhou, Huanyu ; Morales, Maria Gabriela ; Chen, Beibei ; Bassel-Duby, Rhonda ; Olson, Eric N. / Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity. In: Stem Cell Reports. 2017 ; Vol. 8, No. 3. pp. 548-560.
@article{15e1dc6d459f46cfb73a3f0109ef51b2,
title = "Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity",
abstract = "Conversion of fibroblasts into functional cardiomyocytes represents a potential means of restoring cardiac function after myocardial infarction, but so far this process remains inefficient and little is known about its molecular mechanisms. Here we show that DAPT, a classical Notch inhibitor, enhances the conversion of mouse fibroblasts into induced cardiac-like myocytes by the transcription factors GATA4, HAND2, MEF2C, and TBX5. DAPT cooperates with AKT kinase to further augment this process, resulting in up to 70{\%} conversion efficiency. Moreover, DAPT promotes the acquisition of specific cardiomyocyte features, substantially increasing calcium flux, sarcomere structure, and the number of spontaneously beating cells. Transcriptome analysis shows that DAPT induces genetic programs related to muscle development, differentiation, and excitation-contraction coupling. Mechanistically, DAPT increases binding of the transcription factor MEF2C to the promoter regions of cardiac structural genes. These findings provide mechanistic insights into the reprogramming process and may have important implications for cardiac regeneration therapies.",
keywords = "cardiomyocytes, cell-fate conversion, DAPT, direct cellular reprogramming, heart regeneration, Notch signaling, regenerative medicine, transdifferentiation",
author = "Maria Abad and Hisayuki Hashimoto and Huanyu Zhou and Morales, {Maria Gabriela} and Beibei Chen and Rhonda Bassel-Duby and Olson, {Eric N.}",
year = "2017",
month = "3",
day = "14",
doi = "10.1016/j.stemcr.2017.01.025",
language = "English (US)",
volume = "8",
pages = "548--560",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity

AU - Abad, Maria

AU - Hashimoto, Hisayuki

AU - Zhou, Huanyu

AU - Morales, Maria Gabriela

AU - Chen, Beibei

AU - Bassel-Duby, Rhonda

AU - Olson, Eric N.

PY - 2017/3/14

Y1 - 2017/3/14

N2 - Conversion of fibroblasts into functional cardiomyocytes represents a potential means of restoring cardiac function after myocardial infarction, but so far this process remains inefficient and little is known about its molecular mechanisms. Here we show that DAPT, a classical Notch inhibitor, enhances the conversion of mouse fibroblasts into induced cardiac-like myocytes by the transcription factors GATA4, HAND2, MEF2C, and TBX5. DAPT cooperates with AKT kinase to further augment this process, resulting in up to 70% conversion efficiency. Moreover, DAPT promotes the acquisition of specific cardiomyocyte features, substantially increasing calcium flux, sarcomere structure, and the number of spontaneously beating cells. Transcriptome analysis shows that DAPT induces genetic programs related to muscle development, differentiation, and excitation-contraction coupling. Mechanistically, DAPT increases binding of the transcription factor MEF2C to the promoter regions of cardiac structural genes. These findings provide mechanistic insights into the reprogramming process and may have important implications for cardiac regeneration therapies.

AB - Conversion of fibroblasts into functional cardiomyocytes represents a potential means of restoring cardiac function after myocardial infarction, but so far this process remains inefficient and little is known about its molecular mechanisms. Here we show that DAPT, a classical Notch inhibitor, enhances the conversion of mouse fibroblasts into induced cardiac-like myocytes by the transcription factors GATA4, HAND2, MEF2C, and TBX5. DAPT cooperates with AKT kinase to further augment this process, resulting in up to 70% conversion efficiency. Moreover, DAPT promotes the acquisition of specific cardiomyocyte features, substantially increasing calcium flux, sarcomere structure, and the number of spontaneously beating cells. Transcriptome analysis shows that DAPT induces genetic programs related to muscle development, differentiation, and excitation-contraction coupling. Mechanistically, DAPT increases binding of the transcription factor MEF2C to the promoter regions of cardiac structural genes. These findings provide mechanistic insights into the reprogramming process and may have important implications for cardiac regeneration therapies.

KW - cardiomyocytes

KW - cell-fate conversion

KW - DAPT

KW - direct cellular reprogramming

KW - heart regeneration

KW - Notch signaling

KW - regenerative medicine

KW - transdifferentiation

UR - http://www.scopus.com/inward/record.url?scp=85014097486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014097486&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2017.01.025

DO - 10.1016/j.stemcr.2017.01.025

M3 - Article

VL - 8

SP - 548

EP - 560

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 3

ER -